ABT vs OLPX · P/E 25, rev $44.33B vs P/E 70, rev $422.7M
Abbott Laboratories (ABT) versus Olaplex Holdings Inc (OLPX) — a side-by-side from cached financials, not a winner call.
Abbott Laboratories (ABT) is a medical devices company listed on NYSE.
Olaplex Holdings Inc (OLPX) is a specialty retail company listed on US.
Latest reported ABT revenue for 2025-12-31 was $44.33B. Net income was $6.52B. Revenue was up 5.7% from 2024-12-31 to 2025-12-31. ABT currently screens at market cap $154.15B and trailing P/E 24.8.
Latest reported OLPX revenue for 2024-12-31 was $422.7M. Net income was $19.5M. Revenue was down 7.8% from 2023-12-31 to 2024-12-31. OLPX currently screens at market cap $932.3M and trailing P/E 70.0.
ABT currently screens at market cap $154.15B and trailing P/E 24.8. OLPX currently screens at market cap $932.3M and trailing P/E 70.0.
Not investment advice. Open the ABT and OLPX stock pages for the full models.
Not investment advice.